Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-30

Clinical Trial Update: The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update investigating the effect of semaglutide on bone turnover in individuals at increased risk of bone fracture, spanning Phase 1 and Phase 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Morten Frost | Conditions: Osteopenia | Phase 1, Phase 2 | Status: UNKNOWN